Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
Vaccinations01:51

Vaccinations

Overview
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute airway compromise in a patient with long-lasting dyspnea.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic.

Infectious diseases and therapy·2022
Same author

Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.

HIV medicine·2021
Same author

Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.

HIV medicine·2021
Same author

Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.

HIV medicine·2020
Same author

Validation of a commercially available SARS-CoV-2 serological immunoassay.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Related Experiment Video

Updated: May 11, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

[The post-exposure prophylaxis in all its forms].

N Wassilew1, E Boffi El Amari, C Bonfillon

  • 1Unité VIH/sida, Service des maladies infectieuses, HUG, 1211 Genève 14. nasstasja.wassilew@hcuge.ch

Revue Medicale Suisse
|May 24, 2013
PubMed
Summary
This summary is machine-generated.

Physicians evaluate post-exposure prophylaxis (PEP) for HIV and hepatitis B (HBV) exposure. This article reviews current PEP guidelines and upcoming changes in Swiss recommendations.

More Related Videos

Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test
07:54

Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test

Published on: January 19, 2024

Related Experiment Videos

Last Updated: May 11, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test
07:54

Detection of Rabies IgG and IgM Antibodies Using the Rabies Indirect Fluorescent Antibody Test

Published on: January 19, 2024

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Context:

  • Physicians frequently assess the need for post-exposure prophylaxis (PEP) following potential exposure to HIV and hepatitis B virus (HBV).
  • Current international guidelines for PEP, particularly for HIV, have evolved regarding drug selection and initiation timing.
  • Hepatitis C virus (HCV) currently lacks a specific PEP protocol.

Purpose:

  • To summarize the key factors influencing the decision-making process for prescribing PEP based on local guidelines.
  • To provide an overview of the anticipated modifications in the forthcoming Swiss guidelines for PEP.
  • To inform healthcare professionals about updated PEP protocols and considerations.

Summary:

  • This review consolidates the criteria for evaluating PEP indications, focusing on HIV and HBV exposure scenarios.
  • It highlights recent shifts in international PEP guidelines concerning therapeutic choices and treatment windows.
  • The article introduces upcoming changes expected in the 2013 Swiss PEP guidelines.

Impact:

  • Facilitates informed clinical decisions regarding PEP for healthcare providers.
  • Promotes adherence to updated evidence-based prophylaxis protocols.
  • Aims to improve patient outcomes by optimizing PEP strategies for viral exposures.